Combined MRI-TRUS fusion targeted and systematic biopsy versus systematic biopsy alone for the detection of prostate cancer: protocol for a prospective single-centre trial

Combined MRI-TRUS fusion targeted and systematic biopsy versus systematic biopsy alone for the detection of prostate cancer: protocol for a prospective single-centre trial

Introduction The classic way of diagnosing prostate cancer (PCa) is by conducting the 12-core systematic biopsy (SB). However, it has a low detection rate for clinically significant PCa (csPCa) and can lead to the detection of clinically insignificant PCa (cisPCa). Although MRI-transrectal ultrasoun...

Full description

Bibliographic Details
Main Authors: Bin Yang, Kun Zhu, Qin Wei, Xudong Yao, Guang Xu, Yanyan He, Wujianhong Liu, Aimaitiaji Kadier, Danjing Shen, Shengrong Dong, Binghui Zhao, Shiyu Mao, Changcheng Guo, Dongyan Han
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/3/e080593.full

Internet

https://bmjopen.bmj.com/content/14/3/e080593.full

Similar Items